spacer
home >
PUBLICATIONS

 
 
 

spacer

 

Industry Events

12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology

8-11 February 2021, Vienna, Austria

In continuation of the very successful scientific meetings in Budapest, Paris, Berlin, Florence, Geneva, Barcelona, Malta, Istanbul, Lisbon, Glasgow and Granada, the 12th PBP World will be held in Vienna from 8-11 Feb 2021. This every two year held conference has gained an ever increasing impact among the pharmaceutical scientists: With up to 1000 submitted abstracts and about 1300 participants it has become a well-established major meeting, attracting scientists from all over the world.
More info >>

 
News and Press Releases

Save The Date: Bormioli Pharma Envision Press Conference

Bormioli Pharma Envision is a milestone, the first digital event for the company. As part of this important moment, Bormioli Pharma has decided to dedicate a unique presentation to the press. The conference, in virtual mode and by invitation only, will give you the opportunity to learn about the company’s strategies for the future. Andrea Lodetti, CEO of Bormioli Pharma and Andrea Sentimenti, Marketing & Innovation Director, will present a preview of the new organization of the company’s product range, involving participants in the company’s innovation process. Bormioli Pharma’s top management will also show the latest products and new prototypes.
More info >>

 
White Papers

Orthogonal Approaches for the Analysis of Protein Sequence

Ludger Ltd

One of the most important classes of biopharmaceuticals is monoclonal antibodies. They are expressed from living cells, and are consequently subject to complex biochemical pathways. Not all of these routes are fully understood, and many are sensitive to the subtlest of environmental changes. Changes such as these can affect the final biopharmaceutical sequence, structure and post-translational modifications, not to mention any changes that may occur during further purification. This often means that the final product from one batch may be different from the last in another batch. Each batch is a complicated mix of similar molecules, and analysis of the degree of batch-to-batch variation is therefore very important to the establishment of the drug's safety for medicinal use and patient administration.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement